2,024
Views
16
CrossRef citations to date
0
Altmetric
Review

Pathogen-inspired drug delivery to the central nervous system

, , , , &
Article: e944449 | Received 16 Apr 2014, Accepted 22 Jun 2014, Published online: 30 Oct 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shoshy Mizrahy, Anna Gutkin, Paolo Decuzzi & Dan Peer. (2019) Targeting central nervous system pathologies with nanomedicines. Journal of Drug Targeting 27:5-6, pages 542-554.
Read now
Jianghui Hou, Lane A Baker, Lushan Zhou & Robyn S Klein. (2016) Viral interactions with the blood-brain barrier: old dog, new tricks. Tissue Barriers 4:1.
Read now

Articles from other publishers (13)

Wei Lv, Yijiao Liu, Shengnan Li, Lingyan Lv, Hongdan Lu & Hongliang Xin. (2022) Advances of nano drug delivery system for the theranostics of ischemic stroke. Journal of Nanobiotechnology 20:1.
Crossref
Thomas Gabriel Schreiner, Constantin Romanescu & Bogdan Ovidiu Popescu. (2022) The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms. Biomolecules 12:4, pages 538.
Crossref
Haitham G. Abo-Al-Ela. (2020) Are Pathogens Completely Harmful or Useless?. ACS Chemical Neuroscience 11:16, pages 2388-2390.
Crossref
Joel Gruchot, Vivien Weyers, Peter Göttle, Moritz Förster, Hans-Peter Hartung, Patrick Küry & David Kremer. (2019) The Molecular Basis for Remyelination Failure in Multiple Sclerosis. Cells 8:8, pages 825.
Crossref
Vimala N. Bharadwaj, Duong T. Nguyen, Vikram D. Kodibagkar & Sarah E. Stabenfeldt. (2017) Nanoparticle‐Based Therapeutics for Brain Injury. Advanced Healthcare Materials 7:1, pages 1700668.
Crossref
Mie Kristensen & Birger Brodin. (2017) Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors. Journal of Pharmaceutical Sciences 106:9, pages 2326-2334.
Crossref
Mira Oswald, Simon Geissler & Achim Goepferich. (2017) Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies. Molecular Pharmaceutics 14:7, pages 2177-2196.
Crossref
Victor A Levin, Lauren E Abrey, Timothy P Heffron, Peter J Tonge, Arvin C Dar, William A Weiss & James M Gallo. (2017) CNS Anticancer Drug Discovery and Development: 2016 conference insights. CNS Oncology 6:3, pages 167-177.
Crossref
Alesia V. Prakapenka, Heather A. Bimonte-Nelson & Rachael W. Sirianni. (2017) Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol. Annals of Biomedical Engineering 45:7, pages 1697-1709.
Crossref
David X. Medina, Kyle T. Householder, Ricki Ceton, Tina Kovalik, John M. Heffernan, Rohini V. Shankar, Robert P. Bowser, Robert J. Wechsler-Reya & Rachael W. Sirianni. (2017) Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo. Journal of Controlled Release 253, pages 172-182.
Crossref
Saak V. Ovsepian, Valerie B. O’Leary, Vasilis Ntziachristos & J. Oliver Dolly. (2016) Circumventing Brain Barriers: Nanovehicles for Retroaxonal Therapeutic Delivery. Trends in Molecular Medicine 22:11, pages 983-993.
Crossref
Rebecca L. Cook, Kyle T. Householder, Eugene P. Chung, Alesia V. Prakapenka, Danielle M. DiPerna & Rachael W. Sirianni. (2015) A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system. Journal of Controlled Release 220, pages 89-97.
Crossref
Kyle T. Householder, Danielle M. DiPerna, Eugene P. Chung, Gregory M. Wohlleb, Harshil D. Dhruv, Michael E. Berens & Rachael W. Sirianni. (2015) Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. International Journal of Pharmaceutics 479:2, pages 374-380.
Crossref